UNC93B1 and metabolic dysfunction-associated steatotic liver disease: Induction of metabolic syndrome, such as type 2 diabetes or nonalcoholic fatty liver disease, should be examined by using Tlr9d13/13 or Unc93b1−/− mice as further study.